CD45 Antibody Blocking Peptide
This product is CD45 Antibody Blocking Peptide. It targets Receptor-type tyrosine-protein phosphatase C. Purification is performed using HPLC.
Product Specifications
Product Name Alternative
B220; CD 45; CD45; cd45 antigen; ec3.1.3.48; CD45R; GP180; GP180; GP 180; L CA; LCA; L-CA; Leukocyte common antigen; LY5; Protein tyrosine phosphatase receptor type C; Protein tyrosine phosphatase receptor type c polypeptide; protein tyrosine phosphatase, receptor type, C; Receptor-type tyrosine-protein phosphatase C; PTPRC; PTPRC_HUMAN; SCID due to PTPRC deficiency; T200; T200 glycoprotein; T200 leukocyte common antigen; Human homolog of severe combined immunodeficiency due to PTPRC deficiency.
Field of Research
Immunology & Inflammation
Storage Conditions
Shipped at 4°C. Stored at -20°C for one year. Avoid repeated freeze/thaw cycles.
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6179260-01 0.1 mL
IRAK2 (Interleukin-1 Receptor-associated Kinase 2, IRAK-2, MGC150550) (HRP)
Sign In for Pricing
View Details MBS6179260-02 5x 0.1 mL
IRAK2 (Interleukin-1 Receptor-associated Kinase 2, IRAK-2, MGC150550) (HRP)
Sign In for Pricing
View Details 